Skip to content

menu

Pharma in Brief logo
HomeAboutContact
Search
Close
Pharmaceuticals and life sciencesIntellectual propertyLife sciences and healthcare
View topics Archives
Subscribe

Pharma in Brief

YearinReview

Subscribe to YearinReview via RSS

Pharma in Brief’s 2025 Year in Review and What to Watch for in 2026

Photo of Fiona SarazinPhoto of Paul JorgensenPhoto of Kristin Wall
By Fiona Sarazin, Paul Jorgensen & Kristin Wall on January 19, 2026

The Pharma in Brief team is looking back at 2025’s most notable legal and regulatory developments in the Canadian pharmaceutical space and highlighting hot topics for 2026. To those who don’t make it to the end of the article, we’ll…

Pharma in Brief

LinkedIn Twitter Facebook RSS YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date with legal and regulatory developments affecting the pharmaceutical industry. Pharma in Brief provides timely updates with a focus on the key take-away you need to know.

Read more

Topics

Archives

Copyright © 2026, Norton Rose Fulbright LLP. All rights reserved.